Bone mineral density in young adults with Prader‐Willi syndrome: A randomized, placebo‐controlled, crossover GH trial

Summary Context The prevalence of osteoporosis is increased in adults with Prader‐Willi syndrome (PWS). In children with PWS, growth hormone (GH) treatment has beneficial effects on bone mineral density (BMD). BMD might deteriorate after cessation of GH at adult height (AH), while continuing GH migh...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical endocrinology (Oxford) Ročník 88; číslo 6; s. 806 - 812
Hlavní autori:	Donze, Stephany H., Kuppens, Renske J., Bakker, Nienke E., van Alfen‐van der Velden, Janiëlle A.E.M., Hokken‐Koelega, Anita C.S.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Wiley Subscription Services, Inc 01.06.2018
Predmet:	adult height Body height Bone density Bone mineral density Children growth hormone treatment Growth hormones Hormone replacement therapy Osteoporosis Prader-Willi syndrome sex steroid replacement therapy Spine (lumbar) Young adults adult height sex steroid replacement therapy bone mineral density growth hormone treatment Prader-Willi syndrome young adults
ISSN:	0300-0664, 1365-2265, 1365-2265
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!